The report "Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region - Global Forecast to 2027", is projected to reach USD 439 million by 2027 from USD 296 million in 2022, at a CAGR of 8.2%.
Browse 146 market data Tables and 47 Figures spread through 208 Pages and in-depth TOC on "Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region - Global Forecast to 2027"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/legionella-testing-market-173145333.html
The increasing need for rapid diagnostics, increasing incidence of disease, growing advancements in bacterial testing, and water testing regulations. However, a lack of reimbursement and difficulties in detection may affect market growth.
The PCR segment accounted for the largest share of the legionella testing market, by test type segment, in 2021
The legionella testing market is segmented into culture methods, urinary antigen tests, direct fluorescent antibody tests, and PCR. The PCR holds the largest share of the legionella testing market in 2021, mainly due to its simplicity and speed.
Water testing segment to register the highest growth rate during the forecast period
The legionella testing market has been segmented into water testing, IVD testing, and other applications. In 2021, the water testing segment accounted for the largest share of the legionella testing market. Factors such as worldwide lifestyle changes and growing elderly population is driving the growth of the market.
The water & other industries segment accounted for the largest share of the legionella testing, by end user segment, in 2021
Based on the end user, the legionella testing market has been segmented into hospitals, diagnostic laboratories, water & other industries, and other end users. In 2021, the water & other industries segment accounted for the largest share of the legionella testing market. The growing population and urbanization, increasing water treatment regulations, and increased demand for new water resources is driving the growth of this segment.
North America is the largest regional market for legionella testing market
The global legionella testing market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the legionella testing market. The North American legionella testing market growth can be attributed to the growing incidence of legionella-related diseases and growing elderly population.
The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), IDEXX Laboratories, Inc. (US), bioMérieux S.A. (France), Becton, Dickinson, and Company (US), Alere, Inc. (US), Eurofins Scientific (Luxembourg), Roche Diagnostics (Switzerland), Pall Corporation (Danaher) (US), Quidel Corporation (US), Eiken Chemical Co., Ltd. (Japan), Hologic, Inc. (US), QIAGEN (Germany), Takara Bio, Inc. (Japan), Environmental Safety Technologies, Inc. (US), Hydrosense (Scotland), Accepta Ltd. (UK), LuminUltra Technologies Ltd. (Canada), Pro-Lab Diagnostics, Inc. (Canada), BioAlert Solutions (Canada), Pacific Water Technology (Australia), Aquacert Ltd. (UK), DTK Water (UK), Sens Solutions (Spain), Genomadix, Inc. (US), and Phigenics, LLC (US).
Don’t miss out on business opportunities in Legionella Testing Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441